TrialInternational journal of hematology2026

Belantamab mafodotin, pomalidomide, and dexamethasone in Japanese patients with RRMM in the phase 3 DREAMM-8 trial.

Kazutaka Sunami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.